Det medisinske fakultet

Institutt for indremedisin, Seksjon for onkologi

Produksjonsdato : 2001-01-20
Katalogtype: Kortformat.

1
Aamdal, S; Ekanger,  Roald; Klepp,  O
Malignt melanom. Cytostatica Medikamentell kreftbehandling. Inst. for
farmakoterapi, Univ.i Oslo/Den Norske Kreftforening 359 - 362 Oslo 1999.

2
Anker, Gun Birgitta; Refsum, Helga; Ueland, Per Magne; Johannessen, Dag
Clement; Lien, Ernst Asbjørn; Lønning, Per Eystein
Influence of aromatase inhibitors on plasma total homocysteine levels in
postmenopausal breast cancer patients. Clinical Chemistry. 45: 252 - 256
1999.

3
Bernier, J; Denekamp,  J; van Glabbeke,  M; Pierart,  M; Rojas,  A; Trovo,
 M; Horiot,  JC; Antognoni,  P; Dahl,  Olav; Richaud,  P; Kaanders,  J
ARCON: accelerated radiotherapy with carbogen and nicotinamide in     non
small cell lung cancer: a phase I/II study by EORTC. Radiotherapy and
Oncology. 52: 149 - 156 1999.

4
Bremnes, RM; Endresen,  P; Sørbye,  Halfdan
Antimetabolitter. Cytosttica Medikamentell kreftbehandling. Inst. for
farmakoterapi, Univ. i Oslo/Den Norske Kreftforening 168 - 187 Oslo 1999.

5
Christoffersen, T; Fodstad,  Ø; Smeland,  EB; Dahl,  Olav
Kreftceller og kjemoterapi. Cytostatica Medikamentell kreftbehandling. Inst.
for farmakoterapi, Univ. i Oslo / Den Norske Kreftforening 13 - 32 Oslo 1999.

6
Dahl, Olav; Aass,  N; Christoffersen,  T
Bivirkninger. Cytostatic Medikamentell kreftbehandling. Inst. for
farmakoterapi, Univ. i Oslo/ Den Norske Kreftforening 55 - 72 Oslo 1999.

7
Dahl, Olav; Christoffersen, T; Kvaløy, Stein O; Baksaas, I
Medikamentell kreftbehandling. Cytostatica Medikamentell kreftbehandling.
Institutt for farmakoterapi, Univ. i Oslo/Den Norske Kreftforening 1 - 430
Oslo 1999.

8
Dahl, Olav; Dalene,  Ronny; Schem,  Baard Christian; Mella,  Olav
Status of clinical hyperthermia. Acta Oncologica. 38: 863 - 873 1999.

9
Diamandis, EP; Helle,  Svein Inge; Yu,  H; Melegos,  DN; Lundgren,  S;
Lønning,  Per Eystein
Prognostic value of plasma prostate specific antigen after megestrol
acetate treatment in patients with metastatic breast carcinoma. Cancer. 85:
891-898 1999.

10
Elomaa, Inkeri; Blomqvist, C; Sæter, G; Nilbert, M; Monge, Odd; Wiebe, T;
Alvegård, Thor A
Chemotherapy in Ewing's sarcoma. Acta Orthopaedica Scandinavia. 70: 69 - 73
1999.

11
Erikstein, B; Varhaug, JE; Lønning, Per Eystein; Kvinnsland, S
Brystkreft. Cytostatica Medikamentell kreftbehandling. Inst. for
farmakoterapi, Univ. i Oslo / Den Norske Kreftforening 304-309 Oslo 1999.

12
Fernberg, JO; Wiklund, T; Monge, Odd; Sundby Hall, K; Sæter, G; Alvegård,
Thor A; Strander, H
Chemotherapy in soft tissue sarcoma. Acta Orthopaedica Scandinavia. 70: 62
- 68 1999.

13
Folkvard Evensen, J; Monge,  Odd; Tausjø,  JE
Kreft i hode og hals. Cytostatica Medikamentell kreftbehandling. Inst. for
farmkoterapi, Univ. i Oslo/Den Norske Kreftforening 377 - 384 Oslo 1999.

14
Geisler, Jürgen; Ormsjø,  I; Helle,  Svein Inge; Ekse,  Dagfinn; Silsand,  T;
Lønning,  Per Eystein
Plasma estrogen fractions in postmenopausal women receiving hormone
replacement therapy: influence of route of administration and
cigarette smoking. Endocrinology. 162: 265 - 270 1999.

15
Haugen, Dagny R. Faksvåg; Lillehaug, JR; Akslen, Lars
Enhanced expression of EGF-receptor and low frequency of ras
mutations in X-ray-induced rat thyroid tumours. Virchows Archiv. 435: 434 -
441 1999.

16
Helle, Svein Inge; Lundgren, S; Geisler, Stephanie; Ekse, Dagfinn; Holly,
Jeff M.P.; Lønning, Per Eystein
Effect of treatment with megestrol acetate on the IGF-system: Time    and
dose dependency. European Journal of Cancer. 35: 1070 - 1075 1999.

17
Holte, Harald; Schem, Baard Christian; Kolstad, A; Heikkillä, R; Kvaløy,
Stein O
Maligne lymfomer. Cytostatica Medikamentell kreftbehandling. Inst. for
farmakoterapi, Univ. i Oslo/Den Norske Kreftforening 279 - 298 Oslo 1999.

18
Klepp, O; Norum,  J; Dahl,  Olav; Fosså,  SD
Testikkelkreft. Cytostatica Medikamentell kreftbehandling. Inst. for
farmakoterapi, Univ. i Oslo / Den Norske Kreftforening 339 - 345 Oslo 1999.

19
Kristensen, VN; Haraldsen,  EK; Anderson,  KB; Lønning,  Per Eystein;
Erikstein,  B; Kåresen,  R; Gabrielsen,  OS; Børresen-Dale,  AL
CYP17 and breast cancer risk: the polymorphism in the 5' flanking     area
of the gene does not influence binding to SP-1. Cancer Research. 59: 2825 -
2828 1999.

20
Letocha, HS; Fosså, SD; Smaaland, Rune; Tveter, K
Kreft i nyre, ureter, urinblære og prostata. Cytostatica Medikamentell
kreftbehandling. Inst. for farmakoterapi, Univ. i Oslo/Den Norske
Kreftforening 331 - 338 Oslo 1999.

21
Lind, G; Dahl,  Olav; Wist,  E
Stråleskader etter brystkreftbehandling ved Radiumhospitalet 1975-86.
Erstatningsutvalget for stråleskader. Sosial- og helsedepartementet 1 - 115
Oslo 1999.

22
Love, RR; Anker, Gun Birgitta; Yang, Y; Refsum, Helga; Ueland, Per Magne;
Lønning, Per Eystein
Serum homocysteine levels in postmenopausal breast cancer patients
treated with tamoxifen. Cancer Letters. 145: 73 - 77 1999.

23
Lønning, Per Eystein
Cross-resistance to different aromatase inhibitors in breast cancer
treatment. Endocrine Related Cancer. 6: 251 - 257 1999.

24
Lønning, Per Eystein
Exemestane A viewpoint. Drugs. 58: 681 1999.

25
Lønning, Per Eystein; Lien, Ernst Asbjørn; Tveter, K; Christoffersen, T
Hormoner og hormonantagonister. Cytostatica Medikamentell kreftbehandling.
Inst. for farmakoterapi, Univ. i Oslo / Den Norske Kreftforening 226 - 240
Oslo 1999.

26
Lønning, Per Eystein; Johnsen,  H; Geisler,  Stephanie; Aas,  Turid;
Smith-Sørensen,  B; Akslen,  LA; Børresen-Dale,  AL
TP53 as a predictor of response to chemotherapy in breast cancer. ESO
Scientific Updates. 4: 73 - 88 1999.

27
Mella, Olav; Melien,  Ø; Bjordal,  K; Kaasa,  S
Kvalme og oppkast ved cytostaticabehandling. Cytostatica Medikamentell
kreftbehandling. Inst. for farmakoterapi, Univ. i Oslo/Den Norske
Kreftforening 96 - 103 Oslo 1999.

28
Schem, Baard Christian; Ose, T; Fluge, Gjermund
Ernæring til kreftpasienter. Cytostatica Medikamentell kreftbehandling.
Inst. for farmakoterapi, Univ. i Oslo/Den Norske Kreftforening 118 - 127
Oslo 1999.

29
Sigurdsson, F; Cunningham,  D; Dahl,  Olav; Gustavsson,  E; Österlund,  P;
Hansen,  F; Jakobsen,  A; Väisänen,  A; Åbo,  K; Mejer,  J
Adjuvant chemotherapy for colorectal cancer. Colorectal cancer. Current
status and future perspectives. The first Nordic Symposium on Colorectal
Cancer 185 - 191 Danmark 1999.

30
Sæter, G; Wiebe, T; Follerås, G; Alvegård, Thor A; Monge, Odd; Wahlqvist, Y;
Engstöm, K; Forestier, E; Holmström, T; Stenwig, AE; Willén, H; Brosjö, O
Chemotherapy in osteosarcoma. Acta Orthopaedica Scandinavia. 70: 74 - 82
1999.

31
Sæter, G; Monge,  Odd; Sundby Hall,  K; Follerås,  G
Sarkomer. Cytostatica Medikamentell kreftbehandling. Inst. for
farmakoterapi, Univ. i Oslo/Den Norske Kreftforening 363 - 370 Oslo 1999.

32
Telhaug, R; Haugen, Dagny R. Faksvåg; Varhaug, Jan Erik; Gladhaug, IP
Endokrine svulster. Cytostatica Medikamentell kreftbehandling. Inst. for
farmakoterapi, Univ. i Oslo/Den Norske Kreftforening 325 - 330 Oslo 1999.

33
Thoresen, GH; Aamdal, S; Smaaland, Rune
Andre cytostatica. Cytostatica Medikamentell kreftbehandling. Inst. for
farmakoterapi, Univ. i Oslo/Den Norske Kreftforening 209 - 225 Oslo 1999.

34
Tveit, Kjell Magne; Bergan, A.; Dahl, Olav; Giercksky, K-E; Myrvold, H;
Norum, J; Skarstein, A; Solheim, K
Kolorektalcancer og analcancer. Kolorektalcancer og analcancer En
veiledning for leger. Norsk Gastrointestinal Cancer Gruppe /Den Norske
Kreftforening 1 - 67 Oslo 1999.

35
Tveit, KM; Dahl, Olav; Kvaløy, Stein O
Behandling med cytostatica. Cytostatica. Medikamentell kreftbehandling.
Inst. for farmakoterapi, Univ. i Oslo/Den Norske Kreftforening 33 - 40 Oslo
1999.

36
Tveit, KM; Giercksky, K-E; Dahl, Olav
Gastrointestinal kreft. Cytostatica Medikamentell kreftbehandling. Inst. for
farmakoterapi, Univ. i Oslo/Den Norske Kreftforening 310 - 317 Oslo 1999.

37
Wisløff, F; Mella,  Olav; Dahl,  IM
Myelomatose. Cytostatica Medikamentell kreftbehandling. Inst. for
farmakoterapi, Univ. i Oslo/Den Norske Kreftforening 299 - 303 Oslo 1999.

38
Øgreid, P; Berner, AA; Dahl, Olav; Retterdal, E; Fosså, SD
Tissue prostate-specific antigen and androgen receptor
immunoreactivity in prostate cancer biopsies before, during and after
neo-adjuvant androgen deprivation followed by radiotherapy. European Journal
of Urology. 36: 116 - 122 1999.

39
Øvrebø, Kjell; Svardal, A; Kvinnsland, Steinar; Grong, Ketil; Svanes, Knut;
Sørbye, Halfdan
Glutathione modulation changes the penetration of
N-3H-methyl-N-nitro-N-nitrosoguanidine into the gatric mucosa of rats.
Digestive Diseases Science. 44: 2063 - 2075 1999.


<- forrigeinnholdneste ->